INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Indiana native honored as hero after Columbine
When a basketball gym gets a name, you might say it takes on an attitude and a spirit.
Park Tudor hires law firm for investigation
Park Tudor has hired a law firm to conduct an independent investigation focusing on the allegations against former Park Tudor basketball…
Man killed, woman critically hurt in shooting
One man has been killed and a woman is in critical condition after a shooting on the city's southwest side Friday night.
Dry and cold Saturday. Snow Sunday!
Accumulating snow on Valentine's Day!
Anderson company gives employees a second chance
A business owner in Anderson is providing his employees with more than a paycheck.